Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

February 9, 2024

https://www.globenewswire.com/news-release/2024/02/09/2826838/0/en/Renalytix-to-Participate-in-the-BTIG-MedTech-Digital-Health-Life-Science-Diagnostic-Tools-Conference.html

LONDON and SALT LAKE CITY, Feb. 09, 2024 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ:RNLX) (LSE:RENX) (the “Company”) today announced that the Company will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which will take place February 13-14, 2024 in Snowbird, Utah. Given the format of this event, no formal company presentation is expected. Management will be participating in one-on-one meetings with investors during the event and meetings can be requested through BTIG.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.